Best Abstracts | Valve & Structural Heart | Aortic Valve Session Three

Moderator(s)

• 

  Luis Marroquin, MD, FACC, FESC

  Structural Interventional Cardiologist
  National Institute of Cardiology, Mexico

Presentations:

• 2:00 PM – 2:08 PM ET

  Rate Of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using The Navitor Valve System Using The Cusp Overlap Technique: A Single Center Experience
  

  Speaker: Ahmed Ghoneem, MD – UPMC (Harrisburg)
• 2:08 PM – 2:12 PM ET

  Panel Discussion
• 2:12 PM – 2:20 PM ET

  Surgical Risk Does Not Predict Ischemic Stroke Or Acute Infarction After TAVR: Results Of A Patient-level Pooled Analysis
  

  Speaker: Daniel Grubman, MD
• 2:20 PM – 2:24 PM ET

  Panel Discussion
• 2:24 PM – 2:32 PM ET

  Incongruence Of Antiplatelet Therapy (apt) With Bleeding Risk In Patients After Transcatheter Aortic Valve Replacement (tavr) Is Associated With Higher Bleeding
  

  Speaker: DaeHee Lee, MD – Rutgers NJMS
• 2:32 PM – 2:36 PM ET

  Panel Discussion
• 2:36 PM – 2:44 PM ET

  Does The Outcome Of Heart Failure Patients After Tavi Differ Whether They Have Normal Or Reduced Ventricular Function?
  

  Speaker: Elisha James Ouzan, MD – Hadassah Hebrew University Medical Center
• 2:44 PM – 2:48 PM ET

  Panel Discussion
• 2:48 PM ET

  Adjourn